CP8 — Canadian Phosphate Share Price
0.000.00%
Last trade - 00:00- AU$8.89m
- AU$9.00m
- AU$2.49m
- 41
- 65
- 45
- 50
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.86 | ||
| Price to Tang. Book | 0.86 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 3.57 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -14.38% | ||
| Return on Equity | -15.78% | ||
| Operating Margin | -62.38% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | AU$m | 2.04 | 2.24 | 3.56 | 2.79 | 2.49 | n/a | n/a | 13.46% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Canadian Phosphate Limited is a mineral exploration company focused on advancing its Wapiti and Fernie sedimentary rock phosphate projects in British Columbia, Canada. The Wapiti Mining Project encompasses an area of approximately 78 square kilometers in Northeastern British Columbia, 70 kilometers (km) southeast of Tumbler Ridge in the Peace River Regional District. The Fernie Project encompasses seven subgroups of claims in the Southeastern Kootenay region of British Columbia, such as Marten, Barnes, Crowsnest (Pump Station), Mt. Lyne, North Alexander, Alexander and Bighorn, totaling approximately 108 square kilometers. The Project is located about 20 km to the Northwest and Southwest of Sparwood, British Columbia, a mining town and is located in the Elk Valley that is the home of several large mines providing metallurgical coal. Its products include rock phosphate-powder, rock phosphate-micronized, rock phosphate-granulated, FertAg 0-8-0, and FertAg 0-7-0.
Directors
- Patrick Avery CHM (66)
- Julien Mcinally CFO (49)
- Stephen Keith MDR
- Jo Shearer OTH
- Nova Taylor SEC
- Rebecca Woodman SEC
- Peter Bennetto NED
- James Chisholm NED
- Stuart Richardson NED
- Justyn Stedwell NED
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- August 24th, 2010
- Public Since
- September 2nd, 2013
- Sector
- Chemicals
- Industry
- Basic Materials
- Exchange
- Australian Stock Exchange - SEATS
- Shares in Issue
- 296,460,527
- Address
- Level 5, 126 Phillip Street, SYDNEY, 2000
- Web
- https://canadianphosphate.com/
- Phone
- +61 383955446
- Auditors
- MOORE AUSTRALIA AUDIT (WA)
Upcoming Events for CP8
Fertoz Ltd Annual Shareholders Meeting
Half Year 2025 Fertoz Ltd Earnings Release
Similar to CP8
Agrimin
Australian Stock Exchange - SEATS
Aguia Resources
Australian Stock Exchange - SEATS
Alexium International
Australian Stock Exchange - SEATS
Alpha HPA
Australian Stock Exchange - SEATS
Bio-Gene Technology
Australian Stock Exchange - SEATS
FAQ
What is the Canadian Phosphate share price?
As of Today at 19:45 UTC, shares in Canadian Phosphate are trading at AU$0.03. This share price information is delayed by 15 minutes.
How has the Canadian Phosphate share price performed this year?
Shares in Canadian Phosphate last closed at AU$0.03 and the price had moved by +11.11% over the past 365 days. In terms of relative price strength the Canadian Phosphate share price has outperformed the ASX All Ordinaries Index by +6.52% over the past year.
What are the analyst and broker recommendations for Canadian Phosphate?
There is no consensus recommendation for this security.
Find out moreWhat is the Canadian Phosphate dividend yield?
Canadian Phosphate does not currently pay a dividend.
Does Canadian Phosphate pay a dividend?
Canadian Phosphate does not currently pay a dividend.
When does Canadian Phosphate next pay dividends?
Canadian Phosphate does not currently pay a dividend.
How do I buy Canadian Phosphate shares?
To buy shares in Canadian Phosphate you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Canadian Phosphate?
As of the previous close price of AU$0.03, shares in Canadian Phosphate had a market capitalisation of AU$8.89m.
Where are Canadian Phosphate shares listed?
Here are the trading details for Canadian Phosphate:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: CP8
What kind of share is Canadian Phosphate?
Based on an overall assessment of its quality, value and momentum Canadian Phosphate is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Canadian Phosphate share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Canadian Phosphate share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Canadian Phosphate. Over the past six months, its share price has outperformed the ASX All Ordinaries Index by +48.15%.
As of the last closing price of AU$0.03, shares in Canadian Phosphate were trading -3.35% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Canadian Phosphate PE Ratio?
The Canadian Phosphate PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.03.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Canadian Phosphate?
Canadian Phosphate's management team is headed by:
- Patrick Avery - CHM
- Julien Mcinally - CFO
- Stephen Keith - MDR
- Jo Shearer - OTH
- Nova Taylor - SEC
- Rebecca Woodman - SEC
- Peter Bennetto - NED
- James Chisholm - NED
- Stuart Richardson - NED
- Justyn Stedwell - NED